Times are shown in your local time zone GMT
Ad-blocker Detected - Your browser has an ad-blocker enabled, please disable it to ensure your attendance is not impacted, such as CPD tracking (if relevant). For technical help, contact Support.
e-poster: 20 24 Year Old Women Do Have CIN3 Should We Be Worried?
Abstract presenter Description
Maggie Pan1,2, Wendy Burgess1, Anand Gangji2, Alison Carlin2
1 Waitemata District Health Board
2 Northland District Health Board
Objective: To find out the colposcopy outcomes for women aged 20-24, as this group is now missed in the new cervical screening programme. It would be a concern if women with CIN3 or invasive cancer will wait up to 5 years for screening. We want to know if Maori would be disproportionately affected and if other colposcopy outcomes were equitable between Maori and non-Maori.
Design: Retrospective analysis of existing data was used to look at outcomes prior to the change to the screening programme.
Method: There were 369 referrals to the Northland District Health Board colposcopy service with high-grade smears (HSIL or ASC-H) from July 2015-September 2018. We looked up all clinic letters for outcomes such as treatment received and final histology, then analysed with age and ethnicity.
Results: No invasive cancers were found at 20-24 but 27.7% who were referred to colposcopy for a high-grade smear had CIN3. Of these, 38% were aged 22 or below and they comprise 11% of women aged 20-24 who were referred.
Conclusions: There are women aged 20-22 with CIN3 that would have waited 3-5 years for their first smear under the new scheme. We need more information on the rate of progression of CIN3 in this group. It will be interesting to see if there will be any increase in invasive cancers when women first present for a smear at 25. Outcomes for Maori were similar once referred to colposcopy, but we know Maori are less likely to have smears1 and twice as likely to get cervical cancer2.
References:
1 Waitemata District Health Board
2 Northland District Health Board
Objective: To find out the colposcopy outcomes for women aged 20-24, as this group is now missed in the new cervical screening programme. It would be a concern if women with CIN3 or invasive cancer will wait up to 5 years for screening. We want to know if Maori would be disproportionately affected and if other colposcopy outcomes were equitable between Maori and non-Maori.
Design: Retrospective analysis of existing data was used to look at outcomes prior to the change to the screening programme.
Method: There were 369 referrals to the Northland District Health Board colposcopy service with high-grade smears (HSIL or ASC-H) from July 2015-September 2018. We looked up all clinic letters for outcomes such as treatment received and final histology, then analysed with age and ethnicity.
Results: No invasive cancers were found at 20-24 but 27.7% who were referred to colposcopy for a high-grade smear had CIN3. Of these, 38% were aged 22 or below and they comprise 11% of women aged 20-24 who were referred.
Conclusions: There are women aged 20-22 with CIN3 that would have waited 3-5 years for their first smear under the new scheme. We need more information on the rate of progression of CIN3 in this group. It will be interesting to see if there will be any increase in invasive cancers when women first present for a smear at 25. Outcomes for Maori were similar once referred to colposcopy, but we know Maori are less likely to have smears1 and twice as likely to get cervical cancer2.
References:
1. National Screening Unit, Ministry of Health
2. New Zealand Cancer Registry (NZCR), Ministry of Health
Biographical Information:
Maggie is a first-year training registrar at North Shore Hospital, back in Auckland after having worked in various smaller hospitals around New Zealand. Still trying to navigate the basics of managing a delivery suite but interests outside of this include cervical screening, population health and travelling around our beautiful country.
Maggie is a first-year training registrar at North Shore Hospital, back in Auckland after having worked in various smaller hospitals around New Zealand. Still trying to navigate the basics of managing a delivery suite but interests outside of this include cervical screening, population health and travelling around our beautiful country.